Immunic Expands Leadership Team with Industry Veteran Jon Congleton for Strategic Growth Immunic, Inc. enhances its Board of Directors by appointing Jon Congleton, a biopharmaceutical expert, to drive innovations in neurologic disease therapies.

Immunic Expands Leadership Team with Industry Veteran Jon Congleton for Strategic Growth #United_States #New_York #Biopharmaceutical #Immunic_Inc #Jon_Congleton